Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma
Open Access
- 8 September 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (55) , 93729-93740
Abstract
Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesotheliomaKeywords
This publication has 47 references indexed in Scilit:
- Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and stagingWiener klinische Wochenschrift, 2016
- Consensus Report of the 2015 Weinman International Conference on MesotheliomaJournal of Thoracic Oncology, 2016
- A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) indexJapanese Journal of Clinical Oncology, 2015
- Treatment and survival analyses of malignant mesothelioma in JapanActa Oncologica, 2012
- LATS2 Is a Tumor Suppressor Gene of Malignant MesotheliomaCancer Research, 2011
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in MammalsDevelopmental Cell, 2010
- Mesothelioma Epidemiology, Carcinogenesis, and PathogenesisCurrent Treatment Options in Oncology, 2008
- The TEAD/TEF Family of Transcription Factor Scalloped Mediates Hippo Signaling in Organ Size ControlDevelopmental Cell, 2008
- Malignant mesotheliomaThe Lancet, 2005
- High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.Proceedings of the National Academy of Sciences, 1995